Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The UK’s first minister for life sciences has praised biomedical researchers working across Oxfordshire.

UK minister for life sciences George Freeman MP and Dame Fiona Caldicott, Chair of the Oxford University Hospitals NHS Foundation Trust
UK minister for life sciences George Freeman MP and Dame Fiona Caldicott, Chair of the Oxford University Hospitals NHS Foundation Trust

George Freeman MP was visiting the county today (Friday 18 Dec 2015) to find out more about work being carried out by the NHS and businesses locally as well as by Oxford University, and about how all three are working together to create new treatments and technologies.

Starting at the John Radcliffe Hospital, Mr Freeman met Oxford University’s Regius Professor of Medicine Sir John Bell, Oxford University Hospitals NHS Foundation Trust Chair Dame Fiona Caldicott and Director of Clinical Services Paul Brennan, city council leader Bob Price and Local Enterprise Partnership Chief Executive Nigel Tipple, to discuss economic growth plans for the area and new approaches to integrated health care in the county.

Read more

Similar stories

PRINCIPLE trial finds antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19

Coronavirus COVID-19 General Research

In March 2020, the UK-wide Platform Randomised trial of INterventions against COVID-19 In older people (PRINCIPLE) trial was established as a flexible, platform randomised clinical trial to test a range of potential treatments for COVID-19 that might be suitable for use in the community to help people recover more quickly and prevent the need for hospital admission. The trial is one of three national platform trials for COVID-19 treatments, and complements the RECOVERY and REMAP-CAP trials that focus on hospitalised patients.

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.